| Birth Day | February 08, 1938 |
| Birth Place | India |
| Age | 82 YEARS OLD |
| Died On | 26 June 2017(2017-06-26) (aged 79)\nMumbai, India |
| Birth Sign | Pisces |
| Residence | Mumbai, India |
| Citizenship | Indian |
| Alma mater | Bombay University |
| Occupation | Businessman |
| Years active | 1968–2017 |
| Organization | Lupin Limited |
| Known for | Founder and chairman, Lupin Limited |
| Children | 5, including Vinita D. Gupta and Nilesh Gupta |
| Website | www.lupinworld.com |
Desh Bandhu Gupta, also known as the prominent healthcare figure in India, has amassed an estimated net worth of $4.7 billion in 2024. Recognized for his remarkable contributions to the healthcare sector, Gupta has established himself as a visionary leader and has played a pivotal role in revolutionizing medical services in the country. As the founder and chairman of a renowned pharmaceutical company, his achievements in the field have propelled him to the pinnacle of success. Gupta's immense wealth is a testament to his relentless dedication and unwavering commitment to improving access to quality healthcare in India.
Gupta was born on 30 November 1938 in Rajgarh, Alwar, Rajasthan, and received a master's degree in chemistry from Bombay University. He was eldest of the five siblings.
Gupta started his career as an associate professor at the Birla Institute of Technology and Science, Pilani, Rajasthan. He quit teaching and decided to be an Entrepreneur as he was "not able to implement ideas into practice". he came to Bombay (now Mumbai) and worked in a small British pharmaceutical Manufacturing company. He founded Lupin in 1968 with a start-up capital of ₹ 5000 borrowing the money from his wife. The first office of Lupin was rented premises in Central Mumbai used for dispatching medicines. Later, with a loan from Central Bank of India of ₹ 8 lakh, it started a factory whose major order was to provide iron and folic acid tablets to the Government of India programmes related to mother and child Health care. Under his leadership, Lupin became a global pharmaceutical company whose consolidated turnover was ₹110,866 million (equivalent to ₹130 billion or US$1.9 billion in 2017) and profit after tax was ₹18,364 million (equivalent to ₹21 billion or US$320 million in 2017) at the end of March 2014.
Gupta set up the Lupin Human Welfare & Research Foundation (LHWRF) in October 1988. LHWRF was set up with the objective of creating a reproducible and evolving model for sustainable rural development with a simple goal of uplifting families living below the poverty line in rural India.
Gupta received a Lifetime Achievement Award during the Pharma Leadership Summit 2009. He was also the recipient of the Ernst and Young Entrepreneur of the Year 2011 – Visionary Leader award.
In 2015, Forbes estimated Gupta's net worth at $7.2 billion, making him the 254th richest person in the world.
